-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SgoAS/jpsPPTodeXCia8Oa9H0ABEFqQ8Rfp7DPsFH4Ee5ZWXtkT5e5zDzZwjM9OD v5no/xlETMGIXZvha/EcwQ== 0000950134-08-002659.txt : 20080214 0000950134-08-002659.hdr.sgml : 20080214 20080214140247 ACCESSION NUMBER: 0000950134-08-002659 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080214 DATE AS OF CHANGE: 20080214 GROUP MEMBERS: JAMES JONES GROUP MEMBERS: KATE MITCHELL GROUP MEMBERS: LOUIS C BOCK GROUP MEMBERS: MARK BROOKS GROUP MEMBERS: RORY O'DRISCOLL GROUP MEMBERS: SCALE VENTURE PARTNERS II LP GROUP MEMBERS: SHARON WIENBAR SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Orexigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001382911 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 651178822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-83422 FILM NUMBER: 08612824 BUSINESS ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 160 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 436-8600 MAIL ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 160 CITY: SAN DIEGO STATE: CA ZIP: 92130 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Scale Venture Management II, LLC CENTRAL INDEX KEY: 0001367512 IRS NUMBER: 270110811 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 950 TOWER LANE, SUITE 700 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650.378.6050 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 700 CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: BA Venture Partners VII, LLC DATE OF NAME CHANGE: 20060626 SC 13G 1 f37662a1sc13g.htm SCHEDULE 13G sc13g
 

 
     
SEC 1745
(3-06)
  Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
     
 
     
 
OMB APPROVAL
 
 
OMB Number: 3235-0145
 
 
Expires: February 28, 2009
 
 
Estimated average burden hours per response...10.4
 
 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. __)*

Orexigen Therapeutics, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
68616404
(CUSIP Number)
12/31/07
(Date of Event Which Requires Filing of This Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     o Rule 13d-1(c)

     þ Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 


 

                     
CUSIP No.
 
68616404 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Scale Venture Partners II, LP     20-1965001
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   2,717,445
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   2,717,445
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  2,717,445
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 2 of 14 pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Scale Venture Management II, LLC     27-0110811
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  California
       
  5   SOLE VOTING POWER
     
NUMBER OF   2,717,445*
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   2,717,445*
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  2,717,445*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  CO
* Shares are held by Scale Venture Partners II, LP. Scale Venture Management II, LLC is the general partner of Scale Venture Partners II, LP.

Page 3 of 14 pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Louis C. Bock
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  US
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   2,717,445*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    2,717,445*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  2,717,445*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
*  Shares are held by Scale Venture Partners II, LP. Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of his proportionate pecuniary interests therein.

Page 4 of 14 pages


 

                     
CUSIP No.
 
6861404
 

 

           
1   NAMES OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Kate Mitchell
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  US
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   2,717,445*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    2,717,445*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  2,717,445*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
*  Shares are held by Scale Venture Partners II, LP. Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of her proportionate pecuniary interests therein.

Page 5 of 14 pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Rory O’Driscoll
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  US
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   2,717,445*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    2,717,445*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  2,717,445*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
*  Shares are held by Scale Venture Partners II, LP. Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of his proportionate pecuniary interests therein.

Page 6 of 14 pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Mark Brooks
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  US
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   2,717,445*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    2,717,445*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  2,717,445*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
*  Shares are held by Scale Venture Partners II, LP. Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of his proportionate pecuniary interests therein.

Page 7 of 14 pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
James Jones
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  US
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   2,717,445*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    2,717,445*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  2,717,445*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
*  Shares are held by Scale Venture Partners II, LP. Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of his proportionate pecuniary interests therein.

Page 8 of 14 pages


 

                     
CUSIP No.
 
68616404 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Sharon Wienbar
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  US
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   2,717,445*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    2,717,445*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  2,717,445*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
*  Shares are held by Scale Venture Partners II, LP. Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of her proportionate pecuniary interests therein.

Page 9 of 14 pages


 

Item 1.
         
 
  (a)   Name of Issuer
 
           Orexigen Therapeutics, Inc.
 
 
  (b)   Address of Issuer’s Principal Executive Offices
 
           12481 High Bluff Drive, Suite 160
 
           San Diego, CA 92130
Item 2.
             
 
  (a)   Name of Person Filing    
             Scale Venture Parnters II, LP; Scale Venture Management II, LLC; Louis C. Bock; Kate
             Mitchell; Rory O’ Driscoll; Mark Brooks; James Jones and Sharon Wienbar
 
           
    (b)   Address of Principal Business Office or, if none, Residence
             Scale Venture Partners II, LP: 950 Tower Lane, Suite 700, Foster City, CA 94404
             Scale Venture Management II, LLC: 950 Tower Lane, Suite 700, Foster City, CA 94404
 
           Louis C. Bock:   950 Tower Lane, Suite 700, Foster City, CA 94404
 
           Kate Mitchell:   950 Tower Lane, Suite 700, Foster City, CA 94404
 
           Rory O’Driscoll:   950 Tower Lane, Suite 700, Foster City, CA 94404
 
           Mark Brooks:   950 Tower Lane, Suite 700, Foster City, CA 94404
 
           James Jones:   950 Tower Lane, Suite 700, Foster City, CA 94404
 
           Sharon Wienbar:   950 Tower Lane, Suite 700, Foster City, CA 94404
 
           
 
  (c)   Citizenship    
             Scale Venture Partners II, LP is organized in Delaware and Scale Venture Management
    II, LLC is organized in California. Each of Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are US citizens.
 
           
 
  (d)   Title of Class of Securities    
 
           Common Stock    
 
           
 
  (e)   CUSIP Number    
 
           68616404    
Item 3. If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable
Item 4. Ownership
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
                 
(a )    
Amount Beneficially Owned:
       
       
Scale Venture Partners II, LP
    2,717,445  
       
Scale Venture Management II, LLC
    2,717,445 (1)
       
Louis C. Bock
    2,717,445 (2)

Page 10 of 14 pages


 

               
     
Kate Mitchell
    2,717,445 (2)
     
Rory O’Driscoll
    2,717,445 (2)
     
Mark Brooks
    2,717,445 (2)
     
James Jones
    2,717,445 (2)
     
Sharon Wienbar
    2,717,445 (2)
     
 
       
(b )  
Percent of Class:
       
     
Scale Venture Partners II, LP
    10.1 %
     
Scale Venture Management II, LLC
    10.1 %
     
Louis C. Bock
    10.1 %
     
Kate Mitchell
    10.1 %
     
Rory O’Driscoll
    10.1 %
     
Mark Brooks
    10.1 %
     
James Jones
    10.1 %
     
Sharon Wienbar
    10.1 %
     
 
       
(c )  
Number of shares as to which the person has:
       
     
(i)     Sole power to vote or to direct the vote:
       
     
 
       
     
Scale Venture Partners II, LP
    2,717,445  
     
Scale Venture Management II, LLC
    2,717,445 (1)
     
 
       
     
(ii)     Shared power to vote or to direct the vote:
       
     
 
       
     
Louis C. Bock
    2,717,445 (2)
     
Kate Mitchell
    2,717,445 (2)
     
Rory O’Driscoll
    2,717,445 (2)
     
Mark Brooks
    2,717,445 (2)
     
James Jones
    2,717,445 (2)
     
Sharon Wienbar
    2,717,445 (2)
     
 
       
     
(iii)     Sole power to dispose or to direct the disposition of:
       
     
 
       
     
Scale Venture Partners II, LP
    2,717,445  
     
Scale Venture Management II, LLC
    2,717,445 (1)
     
 
       
     
(iv)     Shared power to dispose or to direct the disposition of:
       
     
 
       
     
Louis C. Bock
    2,717,445 (2)
     
Kate Mitchell
    2,717,445 (2)
     
Rory O’Driscoll
    2,717,445 (2)
     
Mark Brooks
    2,717,445 (2)
     
James Jones
    2,717,445 (2)
     
Sharon Wienbar
    2,717,445 (2)
 
(1)   Shares are held by Scale Venture Partners II, LP. Scale Venture Management II, LLC is the General Partner of Scale Venture Partners II, LP.
 
(2)   Louis Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks, James Jones and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP.

Page 11 of 14 pages


 

Item 5. Ownership of Five Percent or Less of a Class
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not Applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
Not Applicable
Item 8. Identification and Classification of Members of the Group
Not Applicable
Item 9. Notice of Dissolution of a Group
Not Applicable
Item 10. Certification
Not applicable
[SIGNATURE]
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 12, 2008
                     
SCALE VENTURE PARTNERS II, LP       SCALE VENTURE MANAGEMENT II, LLC    
 
                   
By:
  Scale Venture Management II,
LLC, its General Partner
               
 
                   
By:
  /s/ Louis C. Bock       By:   /s/ Louis C. Bock    
 
                   
 
  Name: Louis C. Bock           Name: Louis C. Bock    
 
  Title: Managing Member           Title: Managing Member    
 
                   
By:
  /s/ Louis C. Bock       By:   /s/ Kate Mitchell    
 
                   
 
  Name: Louis C. Bock           Name: Kate Mitchell    
 
                   
By:
  /s/ Rory O’Driscoll       By:   /s/ Mark Brooks    
 
                   
 
  Name: Rory O’Driscoll           Name: Mark Brooks    

Page 12 of 14 pages


 

                     
By:
  /s/ James Jones       By:   /s/ Sharon Wienbar    
 
                   
 
  Name: James Jones           Name: Sharon Wienbar    
EXHIBITS
A:   Joint Filing Agreement

Page 13 of 14 pages


 

EXHIBIT A
JOINT FILING AGREEMENT
     In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Orexigen Therapeutics, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.
     In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 12th day of February, 2008.
                     
SCALE VENTURE PARTNERS II, LP       SCALE VENTURE MANAGEMENT II, LLC    
 
                   
By:
  Scale Venture Management II,                
 
  LLC, its General Partner                
 
                   
By:
/s/ Louis C. Bock       By: /s/ Louis C. Bock    
 
               
 
Name: Louis C. Bock         Name: Louis C. Bock    
 
Title: Managing Member         Title: Managing Member    
 
                   
By:
/s/ Louis C. Bock       By: /s/ Kate Mitchell    
 
               
 
Name: Louis C. Bock         Name: Kate Mitchell    
 
                   
By:
/s/ Rory O’Driscoll       By: /s/ Mark Brooks    
 
               
 
Name: Rory O’Driscoll         Name: Mark Brooks    
 
                   
By:
/s/ James Jones       By: /s/ Sharon Wienbar    
 
               
 
Name: James Jones         Name: Sharon Wienbar    

Page 14 of 14 pages

-----END PRIVACY-ENHANCED MESSAGE-----